MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from rights
offering
$963K
Net increase
(decrease) in cash ()
-$749K
Net cash provided by
financing activities
$630K
Canceled cashflow
$333K
Net increase
(decrease) in cash ()
-$749K
Canceled cashflow
$630K
Partnership advance
$731K
Share-based compensation
$654K
Depreciation and
amortization
$450K
Amortization of right of use
asset
$290K
Accounts receivable, net
-$260K
Accrued expenses and
other current...
$150K
Prepaid expenses and
other current assets
-$127K
Accounts payable related
party
$35K
Payment of contingent
consideration
$177K
Principal payments of
notes payable
$97K
Principal payment of
financing lease liability
$59K
Net cash used in
operating activities
-$1,311K
Canceled cashflow
$2,697K
Net cash provided by
(used in) investing...
-$68K
Net loss
-$2,893K
Inventory
$360K
Operating lease liability
-$260K
Deferred revenue
-$177K
Gain in spin-off of
nexgelrx
$162K
Change in fair value of
warrant liability
-$118K
Accounts payable
-$38K
Purchases of equipment
$68K
Back
Back
Cash Flow
source: myfinsight.com
NEXGEL, INC. (NXGLW)
NEXGEL, INC. (NXGLW)